Arcus Biosciences (RCUS) Research & Development (2017 - 2026)

Arcus Biosciences' Research & Development history runs 10 years deep, the most recent figure standing at $122.0 million for Q1 2026.

• In Q1 2026, Research & Development changed 0.0% year-over-year to $122.0 million; the TTM figure through Mar 2026 stood at $523.0 million (up 13.45% YoY), while the FY2025 annual figure was $523.0 million, up 16.74% from the prior year.
• Research & Development was $122.0 million for Q1 2026 at Arcus Biosciences, up from $121.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $141.0 million in Q3 2025 to a low of $61.0 million in Q1 2022.
• Historically, Research & Development has averaged $101.2 million across 5 years, with a median of $101.0 million in 2024.
• Biggest YoY gain for Research & Development was 58.14% in 2022; the steepest drop was 8.11% in 2022.
• A 5-year view of Research & Development shows it stood at $80.0 million in 2022, then climbed by 16.25% to $93.0 million in 2023, then advanced by 8.6% to $101.0 million in 2024, then climbed by 19.8% to $121.0 million in 2025, then climbed by 0.83% to $122.0 million in 2026.
• The last three Research & Development figures came in at $122.0 million (Q1 2026), $121.0 million (Q4 2025), and $141.0 million (Q3 2025), per Business Quant data.